Get Sample Pages - Gastric Cancer (Diagnostics and Treatments) Market grow at a CAGR of 14.80% By 2027

Global Gastric Cancer Treatments Market Research Report: Forecast (2022-2027)

By Diagnosis (Blood Tests, Upper Endoscopy, Laparoscopy, Imaging), By Treatment (Chemotherapy, Surgery, Targeted Drug Therapy, Others (Immunotherapy, etc.)), By End-User (Hospitals......, Clinics, Specialized Cancer Centers, Others (Ambulatory Surgery Centers, etc.)), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (The US, Canada, Mexico, Brazil, The UK, Germany, France, Italy, Spain, South Africa, GCC, China, Japan, India, Australia, South East Asia) Read more

Healthcare
Jun 2022
Pages 188
Report Format: PDF, Excel, PPT

Market Definition

Gastric cancer is the abnormal cell growth across the stomach's inner lining, which progresses slowly and shows early signs like indigestion, slight nausea, heartburn, loss of appetite, etc. Yet, the gradual tumour development escalates the severity of symptoms like stomach pain, yellowish eyes or skin, swelling in the stomach, vomiting, blood in stool, constipation, & weight loss, among others. Gastric Cancers are also commonly known as stomach cancers. There are various treatments for this illness, and each depends upon parameters like the stage, patient age, & overall health.

Market Insights

The Global Gastric Cancer Treatments Market is projected to grow at a CAGR of around 14.80% during the forecast period, i.e., 2022-27. The market is driven by the rapidly increasing number of people suffering from Gastric Cancer and rapid developments in the healthcare sector offering quicker diagnosis & effective treatments for the same.

Report Coverage	Details
Study Period	Historical Data: 2017-20
	Base Year: 2021
	Forecast Period: 2022-27
CAGR	14.80%
Regions Covered	North America: The US, Canada, Mexico
	Europe: Germany, The UK, France, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, Rest of Asia Pacific
	South America: Brazil, Argentina, Rest of South America
	Middle East & Africa: Israel, GCC, South Africa, Rest of The Middle East & Africa
Key Companies Profiled	AstraZeneca PLC, Bristol Myers Squibb, Celltrion Inc., Jiangsu Hengrui Medicine Co., Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, Pfizer Inc., Others,
Unit Denominations	USD Million/Billion

Besides, the mounting awareness among people about the availability of diagnosis & treatment of gastric cancer is portraying a swiftly escalating cancer screening tests across different countries worldwide and encouraging the leading biopharma companies to increase their production & distribution capacities to cater to the rising needs of patients for treatment. For instance:

In November 2019, Pfizer & EMD Serono, Inc. revealed positive results from their phase III clinical study on Avelumab for advanced gastric cancer treatment.
In March 2019, AstraZeneca incorporated with Daiichi Sankyo, Inc., for the development & commercialization of an antibody-drug conjugate, Trastuzumab Deruxtecan, under investigation for gastric carcinoma.

Moreover, various research & development activities to bring innovations in existing drugs & introduce new medications for gastric cancer are also augmenting the market growth. It, in turn, is leading to several mergers & acquisitions among prominent players for enhanced product portfolio & improved reachability.

Furthermore, massive support from the governments of different countries worldwide through investments & imposition of favorable policies for various clinical trials of therapies are also playing a prominent role in boosting the Global Gastric Cancer Treatments Market.

Introduction
1. Research Process
2. Assumption
3. Market Segmentation
4. Market Definition
Executive Summary
Global Gastric Cancer Treatments Market Trends & Insights
Global Gastric Cancer Treatments Market Regulation & Policy, By Country
Global Gastric Cancer Treatments Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Gastric Cancer Treatments Market Hotspot and Opportunities
Global Gastric Cancer Treatments Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
    1. Blood Tests
    2. Upper Endoscopy
    3. Laparoscopy
    4. Imaging
  2. By Treatment
    1. Chemotherapy
    2. Surgery
    3. Targeted Drug Therapy
    4. Others (Immunotherapy, etc.)
  3. By End-User
    1. Hospitals
    2. Clinics
    3. Specialized Cancer Centers
    4. Others (Ambulatory Surgery Centers, etc.)
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Competition Characteristics
    2. Revenue Shares
    3. Competitor Placement in MarkNtel Advisor’s Quadrant
North America Gastric Cancer Treatments Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. The US
    2. Canada
    3. Mexico
South America Gastric Cancer Treatments Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. Brazil
    2. Rest of Latin America
Europe Gastric Cancer Treatments Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
Middle East & Africa Gastric Cancer Treatments Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. South Africa
    2. GCC
    3. Rest of Middle East & Africa
Asia-Pacific Gastric Cancer Treatments Market Outlook, 2017- 2027
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. China
    2. Japan
    3. India
    4. Australia
    5. South East Asia
    6. Rest of Asia Pacific
Global Gastric Cancer Treatments Market Key Strategic Imperatives for Success and Growth
Competitive Outlook
1. Competition Matrix
  1. By Application Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Target by Applications
  5. Research & Development
  6. Strategic Alliances
  7. Strategic Initiatives
2. Company Profiles (Business Description, By Application Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. AstraZeneca PLC
  2. Bristol Myers Squibb
  3. Celltrion Inc.
  4. Jiangsu Hengrui Medicine Co., Ltd.
  5. Eli Lilly and Company
  6. GlaxoSmithKline PLC
  7. F. Hoffmann-La Roche AG
  8. Merck & Co., Inc.
  9. Novartis International AG
  10. Pfizer Inc.
  11. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *